Tauriga Sciences Overview

  • Founded
  • 2001
Founded
  • Status
  • Public
  • Employees
  • 2
Employees
  • Stock Symbol
  • TAUG
Stock Symbol
  • Investments
  • 4
  • Share Price
  • $0.16
  • (As of Friday Closing)

Tauriga Sciences General Information

Description

Tauriga Sciences Inc is a revenue generating company that operates through the development, distribution, and licensing of proprietary products as well as evaluation of potential acquisition opportunities. One such opportunity on which the company has acted involves the company having entered into the cannabidiol (or CBD) infused chewing gum product business. This CBD infused chewing gum product has been branded under Tauri-Gum.

Contact Information

Website
Formerly Known As
Novo Energies Corp, Atlantic Wine Agencies, Immunovative
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Holding Companies
Other Industries
Other Pharmaceuticals and Biotechnology
Household Products
Biotechnology
Stock Exchange
PINX
Primary Office
  • 555 Madison Avenue
  • 5th Floor
  • New York, NY 10022
  • United States
+1 (917) 000-0000

Tauriga Sciences Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tauriga Sciences Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.16 $0.14 $0.02 - $0.20 $29.3M 186M 5.36M -$0.02

Tauriga Sciences Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018
EV 5,657 3,397 10,886 2,272
Revenue 260 234 57 0
EBITDA (2,127) (2,130) (814) 295
Net Income (3,347) (3,033) (1,097) (36)
Total Assets 1,028 643 961 689
Total Debt 709 658 214 255
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tauriga Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tauriga Sciences‘s full profile, request access.

Request a free trial

Tauriga Sciences Executive Team (12)

Name Title Board Seat Contact Info
Antonio Treminio Chief Executive Officer & Chief Financial Officer
Seth Shaw Chief Executive Officer & Board Member
Kevin Lacey Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Bruno Vanderschelden Member of Advisory Board
Keith Aqua Chief Medical Officer
You’re viewing 5 of 12 executive team members. Get the full list »

Tauriga Sciences Board Members (5)

Name Representing Role Since
00000 00000000 Self Board Member 000 0000
0000000 00000 Self Board Member 000 0000
0000 0000 Tauriga Sciences Chief Executive Officer & Board Member 000 0000
000000 000000 00 Tauriga Sciences Board Member 000 0000
To view Tauriga Sciences’s complete board members history, request access »

Tauriga Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tauriga Sciences Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 (000 21-Jan-2020 00000 0000000 Environmental Services (B2B)
000000000 10-Jul-2014 000000000000000000 00.000 Personal Products 000000 0000 00.0
00000 000000 28-Jan-2014 000000000000000000 000 Environmental Services (B2B) 000000 0000 00.0
Immunovative Clinical Research 19-May-2011 Merger/Acquisition Other Pharmaceuticals and Biotechnology 0000000 00000000
To view Tauriga Sciences’s complete investments and acquisitions history, request access »